Susan Fleming
About Susan S. Fleming
Independent Director at RLI since 2018; age 54. Background includes private equity investing (Capital Z Financial Services Partners, Insurance Partners Advisors), investment banking (Morgan Stanley), and academia (Senior Lecturer in management/entrepreneurship at Cornell’s School of Hotel Administration and Johnson Graduate School of Management). Education: BA in Economics and Asian Studies (University of Virginia); Master’s and PhD in Management & Organizations (Cornell University). Currently Chair of the Finance & Risk Committee and member of the Audit Committee; classified as Independent under NYSE-aligned standards .
Past Roles
| Organization | Role | Tenure | Committees/Impact |
|---|---|---|---|
| Morgan Stanley & Co. | Analyst | 1992–1994 | Early finance/investment training |
| Insurance Partners Advisors, L.P. | Vice President | 1994–2003 | PE focus on insurance/healthcare |
| Capital Z Financial Services Partners | Partner/Principal | 1998–2003 | PE focus on financial services; M&A, corporate finance |
| Cornell University (School of Hotel Administration; Johnson GSM) | Senior Lecturer (Mgmt/Entrepreneurship) | 2009–2018 | Executive education; leadership and org behavior |
| Cornell University | Masters, PhD | 2004–2009 | Research in Management & Organizations |
External Roles
| Organization | Role | Tenure | Committees/Impact |
|---|---|---|---|
| Virtus Investment Partners, Inc. (NYSE: VRTS) | Director | Current | Public company board experience in asset management |
| Endurance Specialty Holdings, Ltd. | Former Director | Prior | Insurance sector oversight |
| Quanta Capital Holdings, Ltd. | Former Director | Prior | Specialty insurance |
| Ceres Group, Inc. | Former Director | Prior | Health insurance |
| PXRE Group, Ltd. | Former Director | Prior | Reinsurance |
| Universal American Financial Group, Inc. | Former Director | Prior | Medicare insurance |
| Fleming Reinsurance Ltd. | Former Director | Prior | Reinsurance |
Board Governance
- Independence: Classified as Independent; RLI requires majority-independent board and only independent directors on Audit, Human Capital & Compensation, and Nominating & Corporate Governance Committees .
- Committee assignments (2024): Chair, Finance & Investment; member, Audit. Effective Jan 1, 2025, committee renamed to Finance & Risk; she remains Chair; cybersecurity ERM oversight moved to Finance & Risk on Feb 12, 2025 .
- Committee meetings held in 2024: Audit (9), Human Capital & Compensation (5), Finance & Investment (4), Nominating & Corporate Governance (4), Strategy & Risk (4) .
- Attendance: Board met 4 times in 2024; no director attended fewer than 75% of aggregate board and committee meetings; all 12 directors attended the 2024 Annual Meeting of Shareholders .
- Board leadership: Independent Chairman (Duclos) as of May 2, 2024; regular executive sessions of independent directors .
Fixed Compensation
- Structure (2024 program):
- Annual Board retainer: $80,000
- RSUs: $100,000 grant value (time-vested)
- Committee retainers: Audit $15,000; other committees $10,000
- Additional chair retainers: Audit $20,000; Human Capital & Compensation $20,000; other committees $10,000
- Chairman of the Board retainer: $100,000 (half cash/half RSUs) .
- 2025 change: RSU grant value increased to $125,000 effective Jan 1, 2025 (granted upon election at 2025 Annual Meeting) .
| Director Compensation (2024) | Amount ($) |
|---|---|
| Fees Earned or Paid in Cash (Fleming) | 115,000 |
| Stock Awards (RSUs, grant-date fair value) | 99,919 |
| Total | 214,919 |
Notes: Fleming’s $115,000 cash reflects Board retainer ($80k) + Audit committee retainer ($15k) + Finance & Investment committee retainer ($10k) + Chair retainer for Finance & Investment ($10k) .
Performance Compensation
- Director equity grants are time-vested RSUs; no performance metrics are tied to director equity awards (RSUs vest on the earlier of one year after grant or the date of the Annual Meeting). 2024 grant: 698 RSUs (split-adjusted 1,396), with dividend-equivalent RSUs accrued; total RSUs shown in ownership include 1,438 units vesting at the 2025 Annual Meeting .
| Equity Grant Terms (Directors) | Details |
|---|---|
| 2024 RSU grant value | $100,000 |
| RSUs granted (2024) | 698 units (split-adjusted 1,396) |
| Dividend-equivalent RSUs (through 3/17/2025) | Included; total RSUs counted for each director = 1,438 units |
| Vesting | On 2025 Annual Meeting date (or one-year post-grant) |
| 2025 RSU grant value | $125,000 (policy change) |
Other Directorships & Interlocks
- Current: Virtus Investment Partners, Inc. (asset management) .
- No related party transactions disclosed involving Fleming. The only significant related party transaction approved in 2024 involved SS&C Technologies (relationships tied to other directors); committee reviewed and reaffirmed arm’s-length terms, with payments of $570,685 in 2024 .
Expertise & Qualifications
- Financial services, corporate finance, M&A, and organizational leadership, grounded in private equity and investment banking, plus executive education experience .
- Board skills matrix flags: Strategy formulation, financial reporting/audit, risk management/actuarial, human capital management, investments/capital markets/ M&A; insurance/financial services industry knowledge .
Equity Ownership
| Ownership Detail (as of 3/17/2025) | Amount |
|---|---|
| Total beneficially owned shares (Fleming) | 23,105 |
| Included RSUs outstanding | 1,438 units (grant + dividends) |
| Shares in Director Deferred Compensation Plan (rabbi trust) | 17,837 |
| Shares outstanding (company) | 91,770,064 |
| Ownership as % of shares outstanding | ~0.025% (23,105 / 91,770,064) |
- Anti-hedging and anti-pledging: Directors prohibited from hedging and pledging RLI securities; directors/executives cannot hold securities in margin accounts or pledge as collateral .
- Director stock ownership guidelines: 2024 guideline = $500,000; effective Jan 1, 2025 guideline increased to $1,000,000; cannot sell shares until guideline satisfied; Chairman guideline = $1,500,000. As of Dec 31, 2024, all directors met their goal or were within the 5-year window post-appointment .
- Director Deferred Compensation Plan allows deferral of cash/RSUs into mutual fund notional investments or company shares held in a rabbi trust; dividends compound into additional shares .
Say-on-Pay & Shareholder Feedback
| Item | 2024 Vote | 2025 Vote |
|---|---|---|
| Say-on-Pay approval (For/Against/Abstentions) | 38,259,260 / 838,582 / 75,720 | 76,465,973 / 2,955,913 / 120,040 |
| Approx. Approval % | ~97.9% | ~96.3% |
Strong say-on-pay support; HCCC noted >97% approval in 2024 and continued existing program approach .
Governance Assessment
- Strengths:
- Independent director with deep finance/M&A and insurance sector experience; chairs Finance & Risk, now overseeing enterprise risk management and cybersecurity oversight — a core governance function tied to investor confidence .
- High shareholder support for compensation programs (SOP >96%), suggesting alignment with investor expectations .
- Clear anti-hedging/anti-pledging policy for directors; enhanced director ownership guidelines doubled to $1,000,000, reinforcing alignment .
- No director attended fewer than 75% of meetings; independent board leadership and regular executive sessions .
- Potential Red Flags:
- None disclosed specific to Fleming (no related-party transactions or pledging). Noted SS&C related-party transaction involves other directors, but was reviewed/approved under policy with explicit arm’s-length affirmation .
- Signals:
- Elevation of Finance & Risk and migration of cybersecurity oversight signals board prioritization of risk governance, with Fleming in a pivotal chair role .
- Increase in director RSU value (to $125k in 2025) modestly shifts mix toward equity; still time-based (no performance conditions) .
Committee Assignments Snapshot
| Year | Committees | Chair Roles |
|---|---|---|
| 2024 | Audit; Finance & Investment | Chair, Finance & Investment |
| 2025 (post-restructuring) | Audit; Finance & Risk | Chair, Finance & Risk; cybersecurity oversight moved here Feb 12, 2025 |
Director Compensation Program Detail (Structure)
| Component | Amount |
|---|---|
| Annual Board Retainer (cash/electable) | $80,000 |
| Annual RSU Grant | $100,000 (2024); $125,000 (2025) |
| Committee Retainer | Audit $15,000; other committees $10,000 |
| Committee Chair Retainer | Audit $20,000; HCCC $20,000; other committees $10,000 |
| Chairman of the Board Retainer | $100,000 (50% cash/50% RSUs) |
Related Party Transactions (Conflicts Review)
- 2024 SS&C Technologies software licensing/processing services: $570,685 paid; reviewed under Related Party Transaction Policy; affiliations pertain to other directors (Michael: SS&C board; Stone’s family relation to SS&C CEO); none mentioned for Fleming; affirmed comparable to arm’s-length terms .
Additional Notes
- Beneficial ownership context: Directors and executive officers as a group held ~2.16% of shares as of 3/17/2025, reflecting meaningful aggregate insider alignment .
- Board skills and diversity: Matrix highlights cross-functional skills including finance/audit, risk, strategy, IT/cyber, investments/M&A; gender diversity noted (Fleming female) .